item management s discussion and analysis of financial condition and results of operations the following discussion contains  in addition to historical information  forward looking statements within the meaning of section a of the securities act of  as amended  and section e of the securities and exchange act of  as amended  which represent the company s expectations or beliefs 
when used in this report  the words may  could  should  would  believe  anticipate  estimate  expect  intend  plan and similar expressions are intended to identify forward looking statements 
these statements by their nature involve substantial risks and uncertainties  certain of which are beyond the company s control 
the company cautions that various factors  including the factors described in the company s filings with the securities and exchange commission  as well as general economic conditions  changes in applicable laws and regulations  industry trends  a dependence upon and or loss of key employees  vendors or customers  the loss of strategic product shipping relationships  customer demand  product availability  competition including pricing and availability  concentrations of credit risks  distribution efficiencies  capacity constraints and technological difficulties could cause actual results or outcomes to differ materially from those expressed in any forward looking statements of the company 
any forward looking statement speaks only as of the date of this report and the company undertakes no obligation to update any forward looking statement or statements to reflect events or circumstances after the date on which such statements is made or to reflect the occurrence of an unanticipated event 
new factors emerge from time to time  and it is not possible for the company to predict all of such factors 
further  the company cannot assess the impact of each such factor on its business or the extent to which any factor  or combination of factors  may cause actual results to differ materially from those contained in any forward looking statements 
results of operations net sales and operating income loss 
the following table sets forth the net sales and operating income loss for each segment of the company s business for the last three fiscal years year ended march  in thousands net sales waste management services segment    consumer healthcare products segment   company totals    operating income loss waste management services segment    consumer healthcare products segment corporate  company totals    fiscal vs 
fiscal the company s net sales increased by to  in fiscal from  in fiscal the company s operating income decreased to  in fiscal from  in fiscal the company s cost of goods sold increased to of net sales in fiscal from of net sales in fiscal selling  general and administrative expenses including litigation settlements was unchanged at of net sales  in both fiscal and fiscal the results of operations of the company are dependent upon the results of operations of each of its subsidiaries operating in the individual business segments 
set forth below is a discussion of the results of operations of each of these segments 
waste management services segment net sales in the company s waste management services segment  which operates through bio systems  increased to  in fiscal from  in fiscal as in the past few years  the sales growth is primarily due to securing new hospital contracts for bio systems core business of providing sharps sharp edged medical waste such as scalpels  syringes  and needles disposal services which utilize cost effective reusable containers 
due to cost pressures  hospitals continue to be receptive to out sourcing certain services such as sharps management 
additionally  the recent trend toward the formation of hospital networks and bio systems success in marketing its services to these networks has enhanced bio systems sales and market share growth 
market forces and competitive pricing pressures have affected bio systems ability to increase prices with existing hospital and physician customers 
these factors also impact the prices bio systems is able to charge new and potential customers 
bio systems operating income decreased to  in fiscal from  in fiscal bio systems cost of goods sold increased to of its net sales in fiscal  from of net sales in fiscal selling  general and administrative expenses as a percentage of bio systems net sales was unchanged at in both fiscal and fiscal starting in early fiscal and continuing through fiscal  bio systems has had substantial new hospital activity 
preparing new accounts for service requires  among other things  installation of bio systems reusable containers and sometimes considerable operational follow up which causes temporary increases in certain costs and expenses with respect to those accounts 
additionally  bio systems operating payroll and transportation costs and expenses have increased due to the addition of personnel and medical waste transportation vehicles needed to service the new hospital accounts 
as a result of the increase in net sales  bio systems has had better absorption of the costs and expenses associated with the new account installations and service in fiscal compared to prior years 
consumer healthcare products segment net sales for scherer labs  which operates in the company s consumer healthcare products segment  increased to  in fiscal from  in fiscal the increase in scherer labs net sales is due primarily to the following factors i the general increase in the level of business in fiscal year and ii a new contract with wal mart 
through mckesson  its primary distributor  scherer labs began selling the ero ear wax removal system to wal mart in the first quarter of fiscal sales of this product to wal mart during the year were approximately  or of gross sales for the year 
as a result of the increase in net sales  scherer labs operating income increased to  in fiscal from  in fiscal scherer labs cost of goods sold increased slightly to of its net sales in fiscal from in fiscal and its selling  general and administrative expenses decreased to of net sales in fiscal from in fiscal corporate the company s operating expenses at the corporate level increased to  in fiscal from  in fiscal certain administrative  accounting  management oversight and payroll services are performed by the company s corporate office 
the corporate operating expenses include the salaries and wages of the personnel who perform these functions including the company s executive officers  rent expense  and professional accounting and legal fees 
payroll expense at the corporate level decreased in fiscal  as compared to fiscal these payroll reductions will be offset in fiscal because as of april   the company began paying a salary to robert p 
scherer  jr  the company s chairman of the board  president and chief executive officer 
in fiscal and in prior years  the company did not pay mr 
scherer any salary or other compensation for his services 
the company also accrued expenses of  in fiscal to settle a lawsuit that was pending at the end of fiscal fiscal vs 
fiscal the company s net sales increased by to  in fiscal from  in fiscal the company s operating income increased to  in fiscal from  in fiscal the company s cost of goods sold increased slightly to of net sales in fiscal from of net sales in fiscal selling  general and administrative expenses decreased to of net sales in fiscal from of net sales in fiscal set forth below is a discussion of the results of operations of each of the company s business segments for fiscal compared to fiscal waste management services segment net sales in the company s waste management services segment  which operates through bio systems  increased to  in fiscal from  in fiscal as in the past few years  the sales growth is primarily due to securing new hospital contracts for bio systems core business of providing sharps sharp edged medical waste such as scalpels  syringes  and needles disposal services which utilize cost effective reusable containers 
due to cost pressures  hospitals continue to be receptive to out sourcing certain services such as sharps management 
additionally  the recent trend toward the formation of hospital networks and bio systems success in marketing its services to these networks has enhanced bio systems sales and market share growth 
market forces and competitive pricing pressures have affected bio systems ability to increase prices with existing hospital and physician customers 
these factors also impact the prices bio systems is able to charge new and potential customers 
bio systems operating income increased to  in fiscal from  in fiscal bio systems cost of goods sold were of its net sales  which was unchanged compared to fiscal selling  general and administrative expenses as a percentage of bio systems net sales were all unchanged at of net sales in both fiscal and fiscal starting in early fiscal and continuing through fiscal  bio systems has had substantial new hospital activity 
preparing new accounts for service requires  among other things  installation of bio systems reusable containers and sometimes considerable operational follow up which causes temporary increases in certain costs and expenses 
additionally  bio systems operating payroll and transportation costs and expenses have increased due to the additions of personnel and medical waste transportation vehicles needed to service the new hospital accounts 
as a result of the increase in net sales  bio systems has had better absorption of the costs and expenses associated with the new account installations and service in fiscal compared to prior years 
in early fiscal  bio systems was notified by the local taxing authority for its new york processing facility that in previous years it had been billed at an incorrect real estate tax rate 
because of this billing error  it was determined that bio systems owed approximately  in real estate taxes which were to be paid over a one year period 
bio systems bad debt expense increased approximately  to  in fiscal compared with  in fiscal primarily due to the bankruptcy of a hospital network in the fourth quarter of fiscal these increases were partially offset by a decrease in certain administrative costs and expenses such as business liability insurance 
consumer healthcare products segment net sales for scherer labs  which operates in the company s consumer healthcare products segment  decreased to  in fiscal from  in fiscal the decrease in scherer labs net sales is due primarily to the following factors i during the first quarter of fiscal  scherer labs largest customer reduced its buying volume for scherer labs two core products which resulted in a significant decrease in sales orders for these products that continued throughout the year  ii increased competition for scherer labs largest volume product  and iii as a result of industry consolidation  some of scherer labs other customers have either significantly decreased or discontinued their sales order for scherer labs products 
although scherer labs has taken action to regain the lost sales  there can by no assurance that scherer labs will be able to return its sales volume to prior levels 
as a result of the decrease in net sales  scherer labs operating income decreased to  in fiscal from  in fiscal additionally  as a result of the decrease in net sales  scherer labs  cost of goods sold increased to of its net sales in fiscal from in fiscal and its selling  general and administrative expenses increased to of net sales in fiscal from in fiscal scherer labs slightly reduced its warehouse and distribution costs and expenses when it began performing all of its inventory and shipping functions internally in warehouse space leased in one of the company s atlanta georgia facilities 
previously  these functions were performed on a contract basis with a public warehouse dallas  texas 
corporate the company s operating expenses in the corporate segment decreased to  in fiscal from  in fiscal certain administrative  accounting  management oversight and payroll services are performed by the company s corporate office 
the corporate operating expenses include the salaries and wages of the personnel who perform these functions including the company s executive officers  rent expense  and professional accounting and legal fees 
in february  the company relocated its corporate headquarters to another location in atlanta  georgia and as a result reduced its rent expense by  in fiscal  as compared to fiscal the company reduced its legal fees in the corporate segment by  in fiscal  compared to fiscal these payroll reductions will be offset in fiscal because as of april   the company began paying a salary to robert p 
scherer  jr  the company s chairman of the board  president and chief executive officer 
in fiscal and in prior years  the company did not pay mr 
scherer any salary or other compensation for his services 
the functions and responsibilities of the personnel that left the corporate office have either been absorbed by the remaining corporate office staff or have been out sources 
the expenses associated with the out sourcing of certain professional functions has partially offset the savings from the reductions of the corporate office staff 
the company does not allocate any revenues to the corporate segment 
other income expense 
the company recorded interest income of   and  in fiscal   and  respectively 
the significant increase in interest income in fiscal and is a result of the investment  principally in marketable securities see note of notes to consolidated financial statements included elsewhere herein  of the net proceeds received from the marquest transactions in july the company recorded interest expense of  in fiscal and did not record any interest expense in fiscal or the decrease in interest expense is a result of the repayment of the outstanding principal balance on a note payable to the adult children of an affiliate of the company in july the company used a portion of the proceeds from the marquest transactions to repay in full the note payable 
income taxes 
the company recorded an income tax provision of   and  in fiscal  and  respectively 
in fiscal and in prior years  the company utilized tax loss carryforwards and reduced its valuation allowance accordingly 
additionally  in fiscal and in prior years  the company significantly increased its valuation allowance against its deferred tax assets mainly related to the tax loss carryforwards 
liquidity and capital resources the company s cash and cash equivalents totaled  at march   a decrease of  from march  in april  the company invested  in long term high grade marketable securities resulting in a reduction in cash equivalents 
additionally  in october  the company invested  using cash on hand in econometrics  inc see note of notes to consolidated financial statements included elsewhere herein 
with the investment in marketable securities in april  the balance  at fair market value  of the company s long term investments was  at march   as compared to  at march  as a result of the investment in marketable securities in april and the investment in econometrics in october  the company s working capital decreased to  at march  from  at march  the company s long term debt decreased to  at march  from  at march  the primary reasons for these changes are discussed below 
cash flows from operating activities 
the company s cash provided by operating activities from continuing operations totaled  for fiscal  as compared to  for fiscal primarily due to the cash payment of  for the settlement of a lawsuit  bio systems cash provided from operating activities decreased to  for fiscal from  for fiscal as a result of the increase in its net sales  scherer labs cash provided from operating activities increased to  for fiscal from  for fiscal the cash provided by operations at the corporate level increased to  for fiscal from  for the same period in fiscal cash flows from investing and financing activities 
the company s investing activities used cash of  and  in fiscal and  respectively  as compared to fiscal where the company s investing activities provided cash of  fiscal includes the net proceeds received by the company from the sale of marquest to vsi in july the aggregate proceeds received by the company from the transaction  net of costs  was  and the cash held by marquest at the time of the transaction was  during the third quarter of fiscal  the company invested  of the proceeds received from the sale of marquest in long term high grade marketable securities 
in april  the company increased its investment in marketable securities by  when it made an additional investment in fixed income government bonds 
the company s marketable securities are composed of municipal bonds  corporate bonds and preferred stocks and mature over periods ranging from years to years see note of the notes to consolidated financial statements included elsewhere herein 
on october   the company made a cash investment of  in econometrics inc in the form of a five year convertible debenture see note of notes to consolidated financial statements included elsewhere within 
as a result of the growth in business  bio systems made capital expenditures for equipment and containers of   and  in fiscal  and  respectively 
cash used for the company s financing activities was   and  in fiscal   and  respectively 
in july  the company used a portion of the proceeds from the sale of marquest to repay in full the principal balance of  on a note payable to the adult children of an affiliate of the company 
management of the company believes that its current cash on hand and its current cash flow is sufficient to maintain its current operations 
the company is evaluating its long term options with regard to the use of its remaining cash on hand 
year issues 
like many other companies  the year computer issue created risks for the company 
if internal systems did not correctly recognize and process date information beyond the year  there could be an adverse impact on the company s operations 
the company completed its conversion to the new equipment and software at its corporate headquarters in fiscal and bio systems completed its conversion in the second quarter of fiscal the third party vendors that supplied the new hardware and software have informed the company that the new systems and software are year compliant 
to date there have been no year related problems with the computer systems 
item a 
quantitative and qualitative disclosures about market risk none 

